KNB
NEUTRALKanabo Group Plc Faces Temporary Suspension of Listing
The healthcare company is facing a temporary suspension of its listing due to a delay in publishing its annual financial report.
Kanabo Group
0.2250GBX
-25.00%
Market Cap
1.42M
Volume
134.14k
135% of avg
P/E Ratio
EPS (TTM)
Beta
2.79
Day Range
0.0000p - 0.0000p
52 Week Range
0.0000p0.2250p1.5000p
0.2250p
KNB
NEUTRALKanabo Group Provides Business Update
The digital health company is reviewing its strategic direction and assessing its capital needs, as its financial position has become more uncertain.
KNB
NEUTRALKanabo Group Announces Non-Executive Director Resignation
The healthcare company announces the resignation of a Non-Executive Director, citing personal reasons.
KNB
GOODKanabo Group Reports 44% Revenue Growth, Operational Progress
The digital health company reported a 44% increase in revenue for 2024, driven by strategic initiatives. However, the firm continues to evaluate its capital needs and strategic direction.
KNB
NEUTRALKanabo Announces Board Changes as Chairman Departs
Digital health company announces board-level changes, with the departure of its long-serving Chairman.
KNB
GOODKanabo's Subsidiary The GP Service Wins Tech Business of the Year Award
Kanabo's healthcare technology subsidiary wins major industry award, signaling its growth potential.
KNB
NEUTRALKanabo Group Announces Director Shareholding Transfer
Kanabo, a digital health company, announces a director's shareholding transfer with no major business implications.
KNB
NEUTRALKanabo Director Transfers Shares to Daughter
Digital health company Kanabo sees director transaction, with potential short-term impact on share price.
KNB
GOODKanabo Reports 55% Revenue Growth, Expands Digital Health Services
Digital health company reports 55% revenue growth, expands services and technology
KNB
GOODDirectors Boost Confidence in Kanabo Group with Share Purchases
Healthcare technology company sees director share purchases, signaling confidence in the business.